HSBC loses conviction in leading drugmaker, forecasts 'tough path' ahead
HSBC has stopped believing in AstraZeneca's stock. AstraZeneca is a big drug company. It made a mistake in a test for a heart disease.
6.2Significance
1 source7.0Source trust
AstraZeneca's
Connected entities
organizationAnalystsorganizationAstraZenecaorganizationBritish-SwedishorganizationFororganizationHSBCorganizationSharesorganizationThey
Appears in 1 topic(s)